AbbVie Inc.·4

Apr 5, 5:00 PM ET

Sorg Elaine K. 4

4 · AbbVie Inc. · Filed Apr 5, 2023

Insider Transaction Report

Form 4
Period: 2023-04-03
Sorg Elaine K.
Sr. V.P., U.S. Commercial Ops.
Transactions
  • Sale

    Common Stock, $0.01 par value

    2023-04-03$160.03/sh15,002$2,400,77042,829 total
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2023-04-03$93.50/sh+15,002$1,402,68757,831 total
  • Exercise/Conversion

    Option (Right to Buy)

    2023-04-03$93.50/sh15,002$1,402,6870 total
    Exercise: $93.50From: 2021-02-20Exp: 2030-02-19Common Stock (15,002 underlying)
Footnotes (2)
  • [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.00 to $160.05, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Documents

1 file
  • 4
    form4-04052023_050407.xmlPrimary